Xilio Therapeutics, Inc. (XLO)
9.08
+0.07
(+0.78%)
USD |
NASDAQ |
Oct 09, 16:00
9.08
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Price to Book Value : 0.8268 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 0.8204 |
| October 07, 2026 | 0.8204 |
| October 06, 2026 | 0.8195 |
| October 05, 2026 | 0.8295 |
| October 02, 2026 | 0.8204 |
| October 01, 2026 | 0.8113 |
| September 30, 2026 | 0.8241 |
| September 29, 2026 | 0.8138 |
| September 28, 2026 | 0.8241 |
| September 25, 2026 | 0.8231 |
| September 24, 2026 | 0.8195 |
| September 23, 2026 | 0.814 |
| September 22, 2026 | 0.8231 |
| September 21, 2026 | 0.8213 |
| September 18, 2026 | 0.8313 |
| September 17, 2026 | 0.8231 |
| September 16, 2026 | 0.8177 |
| September 15, 2026 | 0.8222 |
| September 14, 2026 | 0.8131 |
| September 11, 2026 | 0.8131 |
| September 10, 2026 | 0.8131 |
| September 09, 2026 | 0.8168 |
| September 08, 2026 | 0.8113 |
| September 04, 2026 | 0.8195 |
| September 03, 2026 | 0.8213 |
| Date | Value |
|---|---|
| September 02, 2026 | 0.8049 |
| September 01, 2026 | 0.8086 |
| August 31, 2026 | 0.815 |
| August 28, 2026 | 0.8195 |
| August 27, 2026 | 0.8204 |
| August 26, 2026 | 0.8241 |
| August 25, 2026 | 0.8268 |
| August 24, 2026 | 0.8368 |
| August 21, 2026 | 0.8405 |
| August 20, 2026 | 0.8405 |
| August 19, 2026 | 0.8568 |
| August 18, 2026 | 0.865 |
| August 17, 2026 | 0.8641 |
| August 14, 2026 | 0.835 |
| August 13, 2026 | 0.8204 |
| August 12, 2026 | 0.8241 |
| August 11, 2026 | 0.8359 |
| August 10, 2026 | 0.8377 |
| August 07, 2026 | 0.835 |
| August 06, 2026 | 0.8441 |
| August 05, 2026 | 0.8295 |
| August 04, 2026 | 0.8277 |
| August 03, 2026 | 0.8241 |
| July 31, 2026 | 0.8295 |
| July 30, 2026 | 0.8268 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cue Biopharma, Inc. | 62.98 |
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.96 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.042 |
Price to Book Value Related Metrics
| PS Ratio | 2.085 |
| Price | 9.08 |
| Earnings Yield | -18.57% |
| Market Cap | 59.75M |